Tests based on ER and PR immunoreactivity and other immunohistochemical (IHC) factors, including such proteins as p53, Ki-67, and Her-2/neu, have been applied in the diagnosis of female mammary neoplasms for years. The gene discussed is ERBB2; the disease is breast cancer.